LSE · Pharmaceuticals
AstraZeneca PLC (AZN) Stock Price & Forecast
£132.80-0.90 (-0.67%)Illustrative delayed price
Key data
- Market cap
- £206bn
- P/E ratio
- 31.4
- Dividend yield
- 1.94%
- Employees
- 94,000
- Headquarters
- Cambridge, United Kingdom
- Founded
- 1999
- Listing
- LSE · United Kingdom
- Currency
- £
About AstraZeneca PLC
AstraZeneca is the FTSE 100's largest company by market value, with an oncology-weighted pipeline and a long-running debate about a US listing.
Analyst ratings & price target
Consensus across 28 covering analysts.
- Consensus
- Buy
- Average target
- £148.00
- High target
- £175.00
- Low target
- £110.00
| Buy | 21 |
|---|---|
| Hold | 6 |
| Sell | 1 |
Earnings
Next report and the most recent quarter on record.
- Next report
- 2026-11-12
- Period
- Q3 2026
- Consensus EPS
- £1.24
- Last reported
- 2026-07-29
- Last EPS
- £1.19
- Last revenue
- £11.8bn
- EPS surprise
- +2.6%
Related stocks
Related coverage
Free newsletter
Market Daily
One email before the US open: the overnight moves, the day's earnings, and the one number worth watching. No tips, no hype.
Prices, valuation multiples, consensus estimates and target prices on this page are illustrative and delayed. Nothing here is investment advice or a recommendation to buy or sell any security. See our editorial standards.